அமைப்பு ஆஃப் முடுக்கப்பட்ட ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The process for developing and approving new therapies for patients has been under scrutiny for at least three decades; concern regarding a broken clinical research system has been voiced by many, including patients and caregivers. Despite global technological advances, the costs and efficiencies associated with bringing a new product to market are going in the wrong direction, (i.e., higher costs with longer cycle times). It is well-documented that research protocols are becoming more complex, the amount of data collected per study is increasing, and cycle times are getting longer (1). Many physicians conduct one study and no more due to excessive administrative burden. Prices for new drugs have skyrocketed. ....

System Of Accelerated Research , Accelerated Research , அமைப்பு ஆஃப் முடுக்கப்பட்ட ஆராய்ச்சி , முடுக்கப்பட்ட ஆராய்ச்சி ,